Metabotropic Glutamate Receptor 2 Market size is estimated to be USD 1.2 Billion in 2024 and is expected to reach USD 2.5 Billion by 2033 at a CAGR of 8.5% from 2026 to 2033.
In 2025, South Korea's Metabotropic Glutamate Receptor 2 (mGluR2) market is projected to reach approximately $31.6 million, with expectations to grow to $57.5 million by 2032, reflecting a compound annual growth rate (CAGR) of 7.8%. This growth is driven by increasing demand in the pharmaceutical and biotechnology sectors, particularly for applications in treating neurological disorders such as schizophrenia, anxiety, and chronic pain.
Key industry players contributing to this market include Takeda Pharmaceutical Company Limited, Eli Lilly and Company, and Novartis AG. These companies are focusing on developing both Positive Allosteric Modulators (PAMs) and Negative Allosteric Modulators (NAMs) to enhance therapeutic outcomes.
From personal experience working within the pharmaceutical industry, there's a noticeable shift towards personalized medicine. This trend emphasizes the need for targeted therapies, making mGluR2 modulators increasingly relevant. Research and development teams are prioritizing the creation of compounds that can offer more precise treatment options with fewer side effects.
The Metabotropic Glutamate Receptor 2 Market in South Korea is also benefiting from government initiatives aimed at supporting biotech innovation. Funding and policy support are enabling startups and established firms to invest in advanced research, leading to a more robust pipeline of mGluR2-targeted therapies.
Industry requirements are evolving, with a focus on:
Enhanced efficacy and safety profiles of mGluR2 modulators.
Scalable manufacturing processes to meet increasing demand.
Compliance with stringent regulatory standards.
Integration of artificial intelligence in drug discovery processes.
As the market continues to expand, collaboration between academia, industry, and regulatory bodies will be crucial in addressing the complex challenges associated with neurological disorders and in bringing innovative mGluR2 therapies to market.
Get an In-Depth Research Analysis of the South Korea Metabotropic Glutamate Receptor 2 Market Size And Forecast [2025-2032]
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Metabotropic Glutamate Receptor 2 Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Metabotropic Glutamate Receptor 2 Market
Agonists
Antagonists
Inverse Agonists
Allosteric Modulators
Neurological Disorders
Psychiatric Disorders
Depression
Anxiety Disorders
Post-synaptic Modulation
Pre-synaptic Modulation
Signaling Pathways
Oral
Intravenous
Intranasal
Subcutaneous
Hospitals
Research Institutions
Pharmaceutical Companies
Specialized Clinics
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Metabotropic Glutamate Receptor 2 Market Research Analysis
1. Introduction of the South Korea Metabotropic Glutamate Receptor 2 Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Metabotropic Glutamate Receptor 2 Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Metabotropic Glutamate Receptor 2 Market, By Type
6. South Korea Metabotropic Glutamate Receptor 2 Market, By Application
7. South Korea Metabotropic Glutamate Receptor 2 Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Metabotropic Glutamate Receptor 2 Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/